ArticleMolecular cancer therapeutics2016

Novel ABCG2 Antagonists Reverse Topotecan-Mediated Chemotherapeutic Resistance in Ovarian Carcinoma Xenografts.

Jerec W Ricci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.